MyAverix Finance
F · Healthcare
immatics biotechnologies GmbH (4A3)
Biotechnology
immatics biotechnologies GmbH (4A3) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4A3
immatics biotechnologies GmbH (4A3) — FAQ
What is 4A3's P/E ratio?
The price-to-earnings (P/E) ratio for immatics biotechnologies GmbH (4A3) is 18.00 (data as of 2026-03-24).
Does immatics biotechnologies GmbH pay a dividend?
Dividend yield is not available in the current snapshot for immatics biotechnologies GmbH (4A3). Check the MyAverix Finance app for the latest dividend data.
What sector is immatics biotechnologies GmbH in?
immatics biotechnologies GmbH (4A3) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4A3 listed on?
4A3 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.